NSC |
Compound |
Enrichment |
Correlation |
NSC 750335 |
(E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one |
0.00845932736945076 |
0.091251465 |
NSC 750743 |
(E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one |
0.00845932736945076 |
0.47263637 |
NSC 752461 |
Null |
0.00845932736945076 |
0.2911047 |
NSC 754240 |
2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one |
0.00845932736945076 |
0.27390224 |
NSC 756170 |
GSK317315A |
0.00845932736945076 |
0.076521411 |
NSC 92915 |
ANTINEOPLASTIC-92915 |
0.00845932736945076 |
0.24671383 |
NSC 113237 |
Null |
0.00845932736945082 |
0.29865755 |
NSC 133072 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.00845932736945082 |
0.093079767 |
NSC 134754 |
Null |
0.00845932736945082 |
0.25127517 |
NSC 274548 |
Gold, [.mu.-[[5,5'-methylenebis[1H-tetrazolato]](2-)-N(1):N(1')]]bis(triphenylphosphine)di- |
0.00845932736945082 |
0.38618867 |